DJ Lee

d=i+ac2 | #要做最好的你 | #fuckcancer | #nottoday

📍 Hong Kong🔄 Updated September 2026💼 6 investments📅 7 years investing🗓 Last invested Mar 2023
Angel investor🌍 Hong Kong
6
Total investments
4
Early stage
1
Mid stage
0
Late stage
7y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Executive Board Member
Mar 2023
Invas provide early detection of vascular diseases and conditions that can lead to serious health complications in heart attack, stroke and limb amputation while identifying and help manage risks in high blood pressure, high cholesterol and smoking. According to WHO, there were 17.9 million deaths related to cardiovascular diseases of which 85% were due to heart attacks and stroke. During the same period, the number of deaths from cancer were 10 million.
Executive Board Member
2023
TWSC is a screening clinic that focuses on the clinical benefits of 3D mammography for the mass market. Based in Novena, TWSC offer 3D mammograms and breast ultrasound at affordable prices so breast screening is all year round and not just in October.
Executive Board Member
2020
Materly is a holding company that it owns in whole or in part, dynamic and primarily growth-oriented businesses in the healthcare and technology sectors.
Executive Board Member
2020
MitaMedtech is the exclusive distributor of a precision cancer treatment technology across selected countries in Asia.
Executive Board Member
2020
SWI is an independent, exclusive and dedicated women’s only clinic specialised in breast diagnostic imaging and interventional services and also offer a comprehensive list of women’s diagnostic imaging and screening services.
Investor
2019
A culture of innovation, a passion for excellence At Mirai Medical, we are passionate about developing technology that greatly improves cancer outcomes and enhances patient experiences. Following intensive research and development, Mirai Medical was formed from a team with over 50 combined years of experience in the areas of pulsed electrical fields, electroporation for cancer, immunotherapy and medical device development to address critical unmet challenges in cancer treatment. We have developed unique IP that allows for outpatient delivery of ePORE therapy which greatly facilitates the ease and improves the outcome of cancer treatment. The ePORE generator has associated probes for targeting tumours located anywhere on the body.
Experience · 6 entries
All (6)
Investments (6)
Board (5)
2023
Executive Board Member
Mar 2023
Invas provide early detection of vascular diseases and conditions that can lead to serious health complications in heart attack, stroke and limb amputation while identifying and help manage risks in high blood pressure, high cholesterol and smoking. According to WHO, there were 17.9 million deaths related to cardiovascular diseases of which 85% were due to heart attacks and stroke. During the same period, the number of deaths from cancer were 10 million.
Executive Board Member
2023
TWSC is a screening clinic that focuses on the clinical benefits of 3D mammography for the mass market. Based in Novena, TWSC offer 3D mammograms and breast ultrasound at affordable prices so breast screening is all year round and not just in October.
2020
Executive Board Member
2020
Materly is a holding company that it owns in whole or in part, dynamic and primarily growth-oriented businesses in the healthcare and technology sectors.
Executive Board Member
2020
MitaMedtech is the exclusive distributor of a precision cancer treatment technology across selected countries in Asia.
Executive Board Member
2020
SWI is an independent, exclusive and dedicated women’s only clinic specialised in breast diagnostic imaging and interventional services and also offer a comprehensive list of women’s diagnostic imaging and screening services.
Show all 6 entries ↓
Investment activity
2019–2023 · 6 investments
201912020320232
Recent (last 2 years)Earlier